NHS England » NHS to overhaul patient communications and end ‘farce’ of invitations arriving after appointment ...

This guide tells you what to expect from your general practice (GP) and how you can help them, so you get the best from the National Health Service (NHS). More details can be found through the links ...

Thousands more people at risk from a virus which causes pneumonia and other serious lung infections will be able to get vital protection on the NHS this winter. From September, all adults aged 65-74 ...

Nearly 2,000 people unknowingly living with HIV have been diagnosed by a pioneering NHS programme, which tests anyone needing a blood test in A&E, saving lives and preventing new infections, shows new ...

Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term. Pembrolizumab – which ...

When I heard this year’s South Asian Heritage Month theme is Unity in Diversity, my first thought was of the power of trust, relationships, and shared purpose in community health. In healthcare, ...

Corridor care is a significant patient safety and experience issue; the NHS is committed to reducing this activity in hospitals across England in both emergency departments and inpatient wards. To ...

Visits to the hay fever advice on the NHS website have more than doubled in the past week as temperatures rise this weekend. There have been 12,990 visits to the hay fever page on ...

The latest NHS England management data has shown the real life and immediate impact of the Medical Training Prioritisation Act. The Act came into force in March responding to concerns about increasing ...

A strategy for the development and/or improvement of acute frailty same day emergency care services. Following publication of the Delivery plan for the recovery of urgent and emergency care services ...

A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive ...

National Institute for Health and Care Excellence (NICE) recommends tirzepatide (Mounjaro®) for the management of obesity for certain patients. Tirzepatide (also called Mounjaro ®) is a weight loss ...